Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/Theophylline Sustained-release Tablets

Approved

化学药品

Theophylline Sustained-release Tablets

拜耳医药（上海）有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 22, 2003
Approval ID: 7zxRXCS08bC
Company: 拜耳医药（上海）有限公司
Type: 化学药品

Approval Details

Approval Id: 7zxRXCS08bC
Approval Number: 国药准字H10970428
Generic Name: 茶碱缓释片
Generic Name En: Theophylline Sustained-release Tablets
Drug Type: 化学药品
Strength: 0.4g
Reg Date: 2003-12-22
Company Name: 拜耳医药（上海）有限公司
Production Company Address: 上海市普陀区景泰路485号
Company Detail Path: /organization/bai-er-yi-yao-shang-hai-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 22, 2003

Approval ID

7zxRXCS08bC

Type

化学药品

Back to NMPA Approvals

茶碱缓释片 - NMPA Drug Approval Details